223 related articles for article (PubMed ID: 23584117)
1. Treatment of alcohol dependence with drug antagonists of the stress response.
Higley AE; Koob GF; Mason BJ
Alcohol Res; 2012; 34(4):516-21. PubMed ID: 23584117
[TBL] [Abstract][Full Text] [Related]
2. Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism.
Lowery EG; Thiele TE
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):77-86. PubMed ID: 20201818
[TBL] [Abstract][Full Text] [Related]
3. Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence.
Walker BM; Valdez GR; McLaughlin JP; Bakalkin G
Alcohol; 2012 Jun; 46(4):359-70. PubMed ID: 22459870
[TBL] [Abstract][Full Text] [Related]
4. Neurocircuitry of alcohol addiction: synthesis from animal models.
Koob GF
Handb Clin Neurol; 2014; 125():33-54. PubMed ID: 25307567
[TBL] [Abstract][Full Text] [Related]
5. Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond.
Ciccocioppo R; Gehlert DR; Ryabinin A; Kaur S; Cippitelli A; Thorsell A; Lê AD; Hipskind PA; Hamdouchi C; Lu J; Hembre EJ; Cramer J; Song M; McKinzie D; Morin M; Economidou D; Stopponi S; Cannella N; Braconi S; Kallupi M; de Guglielmo G; Massi M; George DT; Gilman J; Hersh J; Tauscher JT; Hunt SP; Hommer D; Heilig M
Alcohol; 2009 Nov; 43(7):491-8. PubMed ID: 19913192
[TBL] [Abstract][Full Text] [Related]
6. Effects of the Alpha-1 Antagonist Prazosin on KOR Agonist-Induced Reinstatement of Alcohol Seeking.
Funk D; Coen K; Tamadon S; Lê AD
Int J Neuropsychopharmacol; 2019 Nov; 22(11):724-734. PubMed ID: 31556948
[TBL] [Abstract][Full Text] [Related]
7. The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study.
Kwako LE; Spagnolo PA; Schwandt ML; Thorsell A; George DT; Momenan R; Rio DE; Huestis M; Anizan S; Concheiro M; Sinha R; Heilig M
Neuropsychopharmacology; 2015 Mar; 40(5):1053-63. PubMed ID: 25409596
[TBL] [Abstract][Full Text] [Related]
8. Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings.
Fox HC; Anderson GM; Tuit K; Hansen J; Kimmerling A; Siedlarz KM; Morgan PT; Sinha R
Alcohol Clin Exp Res; 2012 Feb; 36(2):351-60. PubMed ID: 21919922
[TBL] [Abstract][Full Text] [Related]
9. Psychopharmacology. Tackling alcoholism with drugs.
Miller G
Science; 2008 Apr; 320(5873):168-70. PubMed ID: 18403685
[No Abstract] [Full Text] [Related]
10. Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.
Zorrilla EP; Heilig M; de Wit H; Shaham Y
Drug Alcohol Depend; 2013 Mar; 128(3):175-86. PubMed ID: 23294766
[TBL] [Abstract][Full Text] [Related]
11. Findings on alcohol dependence point to promising avenues for targeted therapies.
Kuehn BM
JAMA; 2009 Apr; 301(16):1643-5. PubMed ID: 19383946
[No Abstract] [Full Text] [Related]
12. The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?
Pomrenze MB; Fetterly TL; Winder DG; Messing RO
Alcohol Clin Exp Res; 2017 Dec; 41(12):1986-1999. PubMed ID: 28940382
[TBL] [Abstract][Full Text] [Related]
13. Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism.
Valdez GR; Koob GF
Pharmacol Biochem Behav; 2004 Dec; 79(4):671-89. PubMed ID: 15582675
[TBL] [Abstract][Full Text] [Related]
14. Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.
Logrip ML; Koob GF; Zorrilla EP
CNS Drugs; 2011 Apr; 25(4):271-87. PubMed ID: 21425881
[TBL] [Abstract][Full Text] [Related]
15. Stress-related neuropeptide systems as targets for treatment of alcohol addiction: A clinical perspective.
Heilig M
J Intern Med; 2023 May; 293(5):559-573. PubMed ID: 37052145
[TBL] [Abstract][Full Text] [Related]
16. The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety.
Schank JR; Goldstein AL; Rowe KE; King CE; Marusich JA; Wiley JL; Carroll FI; Thorsell A; Heilig M
Addict Biol; 2012 May; 17(3):634-47. PubMed ID: 22515275
[TBL] [Abstract][Full Text] [Related]
17. Alcoholism: allostasis and beyond.
Koob GF
Alcohol Clin Exp Res; 2003 Feb; 27(2):232-43. PubMed ID: 12605072
[TBL] [Abstract][Full Text] [Related]
18. Dynorphin and its role in alcohol use disorder.
Karkhanis AN; Al-Hasani R
Brain Res; 2020 May; 1735():146742. PubMed ID: 32114059
[TBL] [Abstract][Full Text] [Related]
19. Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues.
Heilig M; Thorsell A; Sommer WH; Hansson AC; Ramchandani VA; George DT; Hommer D; Barr CS
Neurosci Biobehav Rev; 2010 Nov; 35(2):334-44. PubMed ID: 19941895
[TBL] [Abstract][Full Text] [Related]
20. Neuropharmacology of alcohol addiction.
Vengeliene V; Bilbao A; Molander A; Spanagel R
Br J Pharmacol; 2008 May; 154(2):299-315. PubMed ID: 18311194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
